Trastuzumab ELISA Kit (ABIN4886397) | 루미젠코리아
Antibodies-online
hIgG1 Rituximab and Infliximab prepared at 250 ng/mL were assayed and exhibited no cross-reactivity or interference. Quantitative ELISA Kits 15 μL -20°C
제품 사양
| Cat No | ABIN4886397 |
|---|---|
| Manufacturer | Antibodies-online |
| Reactivity | hIgG1, Rituximab, and Infliximab prepared at 250 ng/mL were assayed and exhibited no cross-reactivity or interference. |
| Target | Trastuzumab (Herceptin®) is indicated for the treatment of HER2-positive breast cancer, and adjuvant therapies for metastatic gastric cancer and gastroesophageal cancer. Serum concentration of Trastuzumab may predict some clinical outcome during therapy. It is also possible that the surveillance of circulating Trastuzumab concentration during therapy represents a direct factor for immunogenicity and some other side effects. Identification of biomarkers and risk factors for adverse drug reactions that might be related to serum concentrations, and maintaining the effective minimum concentration of Trastuzumab in order to potentially avoid some side effects, might be beneficial using a reliable method |
| Assay Method | Quantitative |
| Size | 15 μL |
| Storage | -20°C |
Datasheet PDF Provided by Antibodies-online
상세 설명
본 키트는 HER2 양성 유방암 및 위암 치료제인 트라스투주맙의 혈중 농도를 정밀하게 측정하는 정량 분석용 ELISA 제품입니다. 타 항체 의약품과의 교차 반응이 없어 데이터의 신뢰도가 높으며, 치료 반응성 및 면역원성 연구에 최적화된 솔루션을 제공합니다.
This quantitative ELISA kit accurately measures Trastuzumab (Herceptin) levels in human serum samples to monitor therapeutic efficacy and immunogenicity in HER2-positive cancer research.
Trastuzumab ELISA Kit (ABIN4886397)은 루미젠코리아를 통해 국내 구매 및 견적이 가능합니다.
제조사: Antibodies-online | 분류: ELISA Kits
보관 조건: -20 °C | 배송 조건: –
제조사: Antibodies-online | 분류: ELISA Kits
보관 조건: -20 °C | 배송 조건: –